Stocks and Investing Stocks and Investing
Tue, December 6, 2022
[ 12:00 AM ] - WOPRAI
Betsy Graseck Downgraded (STT) to Hold and Held Target at $86 on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Andreas Bokkenheuser Downgraded (STLD) to Hold on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Anthony Powell Maintained (BRX) at Buy with Increased Target to $28 on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Jason Stewart Initiated (BRSP) at Strong Buy and Held Target at $11 on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Eric Hagen Downgraded (BRSP) to Hold on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Kaumil Gajrawala Maintained (CELH) at Hold with Increased Target to $37 on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Daniel Adam Initiated (CCL) at Hold and Held Target at $13 on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Jay Olson Maintained (AMGN) at Buy with Increased Target to $310 on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Curt Woodworth Maintained (AMBP) at Buy with Decreased Target to $8 on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Michael Mueller Maintained (AKR) at Sell with Decreased Target to $16 on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Jessica Fye Maintained (ALKS) at Hold with Decreased Target to $29 on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Kyle Peterson Initiated (ALIT) at Strong Buy and Held Target at $12 on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Steve Powers Downgraded (TAP) to Strong Sell and Held Target at $50 on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Christopher Glynn Downgraded (TEL) to Hold on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
Dean Rosenblum Initiated (TGT) at Buy and Held Target at $190 on, Dec 6th, 2022
[ 12:00 AM ] - WOPRAI
John Staszak Upgraded (UAL) to Strong Buy and Held Target at $52 on, Dec 6th, 2022
Mon, December 5, 2022
[ 12:00 AM ] - WOPRAI
Ravi Shanker Upgraded (UAL) to Buy and Held Target at $67 on, Dec 5th, 2022
[ 12:00 AM ] - WOPRAI
Casey Orr Whitman Initiated (UBSI) at Hold and Held Target at $45 on, Dec 5th, 2022
[ 12:00 AM ] - WOPRAI
Adrienne Yih Maintained (ULTA) at Buy with Increased Target to $548 on, Dec 5th, 2022
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (ULTA) at Hold with Increased Target to $445 on, Dec 5th, 2022
[ 12:00 AM ] - WOPRAI
Zachary Fadem Maintained (TSCO) at Buy with Increased Target to $255 on, Dec 5th, 2022
[ 12:00 AM ] - WOPRAI
Nicole Deblase Downgraded (TEX) to Hold and Held Target at $46 on, Dec 5th, 2022
[ 12:00 AM ] - WOPRAI
Jacob Johnson Maintained (TECH) at Buy with Decreased Target to $105 on, Dec 5th, 2022
[ 12:00 AM ] - WOPRAI
Ravi Shanker Downgraded (ALGT) to Hold and Decreased Target to $115 on, Dec 5th, 2022
[ 12:00 AM ] - WOPRAI
Stephen Trent Initiated (ALK) at Strong Buy and Held Target at $55 on, Dec 5th, 2022
[ 12:00 AM ] - WOPRAI
Sean Lee Initiated (AKTX) at Strong Buy and Held Target at $30 on, Dec 5th, 2022
[ 12:00 AM ] - WOPRAI
Manan Gosalia Initiated (CFR) at Buy and Held Target at $178 on, Dec 5th, 2022
[ 12:00 AM ] - WOPRAI
Rufus Hone Maintained (BX) at Hold with Decreased Target to $90 on, Dec 5th, 2022
[ 12:00 AM ] - WOPRAI
Richard Sunderland Downgraded (SR) to Hold and Decreased Target to $69 on, Dec 5th, 2022
[ 12:00 AM ] - WOPRAI
Andrew Fein Maintained (STOK) at Strong Buy with Decreased Target to $35 on, Dec 5th, 2022

Andrew Fein Maintained (STOK) at Strong Buy with Decreased Target to $35 on, Dec 5th, 2022


Published on 2024-10-28 00:26:47 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Maintained "Stoke Therapeutics, Inc." (STOK) at Strong Buy with Decreased Target from $70 to $35 on, Dec 5th, 2022.

Andrew has made no other calls on STOK in the last 4 months.



There are 2 other peers that have a rating on STOK. Out of the 2 peers that are also analyzing STOK, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew

  • Judah Frommer of "Credit Suisse" Maintained at Buy with Decreased Target to $38 on, Tuesday, November 15th, 2022
  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $25 on, Monday, November 14th, 2022
Contributing Sources